Aekta S. Shah
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Rhinocerebral mucormycosis: a potential source of false-positive uptake on [18F]FET PET/MR leading to diagnostic ambiguity.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 12, 2026
H3K27M-altered diffuse midline glioma: Experience and outcomes from a low-middle income country setting in the contemporary era.
Journal: Neuro-oncology advances
Published: December 19, 2025
Outcomes From a Contemporary Mono-Institutional Cohort of Histone-Mutant Diffuse Hemispheric Glioma: A Rare and Aggressive Pediatric-Type High-Grade Primary Brain Tumor.
Journal: Brain tumor research and treatment
Published: May 18, 2025
Memantine to preserve memory and neurocognition following craniospinal irradiation (MEMENTO): a phase 3 randomized controlled trial.
Journal: BMC cancer
Published: May 18, 2025
Neoadjuvant Chemotherapy and Low Dose Immunotherapy in Resectable Non-small Cell Lung Cancer: A Multi-center Retrospective Cohort Analysis.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: January 31, 2025
Spinal Diffuse Midline Glioma H3 K27M-Altered: Report of a Rare Tumor with Extracranial Skeletal Metastases and Review of Literature.
Journal: International journal of surgical pathology
Published: October 08, 2024
Study Protocol of a Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma (CHROME).
Journal: Cancer medicine
Published: July 19, 2024
Preliminary evaluation of FAPI-04-PET/CT for differentiating recurrence and post-treatment changes in high-grade gliomas.
Journal: Exploration of targeted anti-tumor therapy
Published: July 10, 2024
FET PET to differentiate between post-treatment changes and recurrence in high-grade gliomas: a single center multidisciplinary clinic controlled study.
Journal: Neuroradiology
Published: March 14, 2024
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancers.
Journal: JNCI cancer spectrum
Published: February 16, 2024
The Role of Systemic Therapy in Patients with Advanced Non-small Cell Lung Cancer and a Poor Eastern Cooperative Oncology Group Performance Status.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: November 18, 2023
Last Updated: 09/26/2026